Burning Rock Biotech
(NASDAQ:BNR)
$0.8326
0.0326[4.07%]
At close: May 14
$0.8326
0[0.00%]
PreMarket: 5:01PM EDT
Burning Rock Biotech Ltd recently split on Wednesday, May 15, 2024 with a ratio of 1:10
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Burning Rock Biotech Stock (NASDAQ:BNR), Quotes and News Summary

Burning Rock Biotech Stock (NASDAQ: BNR) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.0 / 4.815K
Day Range- - -
52 Wk Range5.722 - 29.500
Market Cap$85.414M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
16
Short Interest
4.43%
Days to Cover17.77

Recent News

Sinking Burning Rock Faces De-Listing. But Could Privatization Bid Come First?
Key Takeaways: Burning Rock announced its shares could be delisted due to prolonged trading below the required $1 threshold The cancer detection specialist’s former biggest revenue source tumbled 40.6% in the third quarter amid an industry crackdown, spotlighting a major risk for Chinese companies By Doug Young
The Bamboo Works
New Horizon Health Finds Formula For Profits Ahead Of Schedule
Key Takeaways: New Horizon Health posted a 61.3 million yuan adjusted profit in the first half of 2023, benefiting from soaring revenue for its three approved products The company sees big growth potential for its home-based cervical cancer screening product By Molly Wen
The Bamboo Works
Burning Rock Narrows Losses With Drug Research As New Driver
Key Takeaways: Burning Rock’s net loss narrowed 29% to 185 million yuan in the first quarter from the same period a year earlier, helped by lower R&D and sales expenses Revenues from R&D services for drug companies more than doubled, becoming the company’s latest growth engine By Molly Wen
The Bamboo Works
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
4.7
Strong Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BNR
IMNM

FAQ

Q

How do I buy Burning Rock Biotech (BNR) stock?

A

You can purchase shares of Burning Rock Biotech (NASDAQ: BNR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Burning Rock Biotech's (BNR) competitors?

A

Other companies in Burning Rock Biotech’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA), 89bio (NASDAQ:ETNB) and Zentalis Pharma (NASDAQ:ZNTL).

Q

What is the target price for Burning Rock Biotech (BNR) stock?

A

The latest price target for Burning Rock Biotech (NASDAQ: BNR) was reported by CICC on Wednesday, July 14, 2021. The analyst firm set a price target for 39.94 expecting BNR to rise to within 12 months (a possible 4697.02% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Burning Rock Biotech (BNR)?

A

The stock price for Burning Rock Biotech (NASDAQ: BNR) is $0.8326 last updated May 14, 2024 at 5:01 PM EDT.

Q

Does Burning Rock Biotech (BNR) pay a dividend?

A

There are no upcoming dividends for Burning Rock Biotech.

Q

When is Burning Rock Biotech (NASDAQ:BNR) reporting earnings?

A

Burning Rock Biotech’s Q1 earnings are confirmed for Tuesday, May 28, 2024.

Q

Is Burning Rock Biotech (BNR) going to split?

A

There is no upcoming split for Burning Rock Biotech.

Q

What sector and industry does Burning Rock Biotech (BNR) operate in?

A

Burning Rock Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch